4 ms·
Regarding the effectiveness of the vaccine. A challenge trial where healthy people are deliberately infected after receiving the vaccine could very easily have
by fasteddie31003 6y ago
Regarding the effectiveness of the vaccine. A challenge trial where healthy people are deliberately infected after receiving the vaccine could very easily have answered this question. The FDA did not do this and should have IMO. I believe the UK is now taking the lead here and doing challenge trials.
- XorNot 6y agoI'd argue that doing that now, when we have a much better understanding of how to treat the virus, is quite a different proposition to the start of the year when we didn't. Because if it doesn't work, you haven't had a doctor give someone something with unforseen side-effects: they injected them with a deadly virus and killed them (in the worst case). Now we have treatments like Regeneron which the President received, which most likely made a very big difference in his fairly rapid convalescence - doing it when you have more plausible interventions if it doesn't work is quite different. I mean all of this stuff is, relatively, going at lightning pace - if we have a vaccine early next year, that's what, 1.5 years between initial detection and immunization for a novel virus? That is breakneck pace.